Oncology Forecasting
Please fill in the form to receive complimentary access to our whitepaper 'Oncology Forecasting'.
Resources
-
Filter by:
-
-
-
How Pharmaceutical Pricing Data Influences Pricing Strategies In Launch Programs
Fill in the form to receive complimentary access to our whitepaper 'How Pharmaceutical Pricing Data Influences Pricing Strategies In Launch Programs'.
-
How To Evaluate Good EPI Data
Fill in form to receive complimentary access to our whitepaper 'How To Evaluate Good EPI Data'.
-
Black Swan Analysis Brochure
See how we leverage our agile consultancy services and comprehensive internal databases; Epiomic ™, RxPriceIndex™, Oncostrat™ & TheJourney™ to make business decisions clear for our clients.
-
Oncostrat Brochure
Visualise and interact with custom-built dynamic forecasts for oncologic disease across 7 countries (EU5, USA and Japan), with the ability to differentiate between treated patients within a disease population by line of treatment and regimen as well as launch product with user-specified parameters.
-
Epiomic Brochure
Explore a broad range of disease populations across at least 27 major global markets with the ability to segment by clinically relevant parameters such as severity scales, co-morbidities, biomarkers and more.
-
Rx Price Index Brochure
RxPriceIndex™ delivers powerful insights and up to data pharmaceutical pricing data so you can understand the pricing landscape by seamlessly searching for and comparing pharmaceutical products across European and American markets.
-
Quantifying The Market Potential for a New Pharmaceutical Grade Diagnostic Imaging Agent
There is currently no industry standard database for Europe that identifies the location of PET/CT imaging sites and potential commercial cyclotron manufacturing sites.
-
Asian Market Expansion for New Infectious Disease Treatment
A global biopharmaceutical company is currently seeking approval to launch a new drug in several Asian countries for the treatment of a chronic, and endemic, infectious disease.
